Deborah Mash, PhD, is a neuroscientist, pharmacologist, and CEO of DemeRx Inc., a drug development company advancing addiction medicines. A University of Miami Professor Emerita, she founded the Brain Endowment Bank, directed NIH-funded research for over thirty years, and conducted the first FDA-authorized clinical trials of ibogaine.